SLSA
SELLAS Life Sciences amends CEO severance terms
SELLAS Life Sciences updated the Change in Control Severance provisions in CEO Angelos Stergiou's agreement. The amendment modifies payout terms for future termination scenarios.
SLSA news
Latest 1 stories · newest Jun 25, 2026
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same SLSA feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/SLSA/newsSTART FREE